ketoconazole and abt-199

ketoconazole has been researched along with abt-199 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Agarwal, SK; Chien, D; Danilov, AV; Gutierrez, M; Hu, B; Lewis, LD; Puvvada, S; Salem, AH; Wong, SL	1

Trials

1 trial(s) available for ketoconazole and abt-199

Article	Year
Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma. British journal of clinical pharmacology, 2017, Volume: 83, Issue:4 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Sulfonamides	2017

Article

Year

Effect of ketoconazole, a strong CYP3A inhibitor, on the pharmacokinetics of venetoclax, a BCL-2 inhibitor, in patients with non-Hodgkin lymphoma.

British journal of clinical pharmacology, 2017, Volume: 83, Issue:4

Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Bridged Bicyclo Compounds, Heterocyclic; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Female; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Middle Aged; Proto-Oncogene Proteins c-bcl-2; Sulfonamides

2017